Table 1.
Characteristics of participants by cumNon-HDL-C duration.
| Characteristics | Total | Durations of cumNon-HDL-C | |||
|---|---|---|---|---|---|
| 0 year | 2 years | 4 years | 6 years | ||
| Subjects, n% | 49,679 | 30,520 (61.4) | 10,026 (20.2) | 5,586 (11.2) | 3,547 (7.1) |
| ASCVD, n% | 1,134 (2.3) | 545 (1.8) | 251 (2.5) | 183 (3.3) | 155 (4.4) |
| Age, years | 52.44 ± 11.75 | 51.49 ± 12.10 | 53.11 ± 11.15 | 54.50 ± 10.82 | 55.46 ± 10.73 |
| Male, n% | 37,851 (76.2) | 23,068 (75.6) | 7,797 (77.8) | 4,299 (77.0) | 2,687 (75.8) |
| Physic, n% | 7,038 (14.2) | 4,028 (13.2) | 1,502 (15.0) | 898 (16.1) | 610 (17.2) |
| Smoke, n% | 17,082 (34.4) | 9,976 (32.7) | 3,603 (35.9) | 2,104 (37.7) | 1,399 (39.4) |
| Drink, n% | 3,054 (6.1) | 1,677 (5.5) | 683 (6.8) | 421 (7.5) | 273 (7.7) |
| HTN, n% | 21,816 (43.9) | 12,046 (39.5) | 4,817 (48.0) | 2,945 (52.7) | 2,008 (56.6) |
| Systolic BP, mmHg | 130.32 ± 19.12 | 128.41 ± 19.77 | 131.91 ± 18.91 | 134.07 ± 19.12 | 136.39 ± 20.11 |
| Diastolic BP, mmHg | 84.22 ± 10.81 | 83.33 ± 10.61 | 85.15 ± 10.81 | 85.84 ± 10.88 | 86.64 ± 11.11 |
| DM, n% | 4,997 (10.1) | 2,331 (7.6) | 1,159 (11.6) | 885 (15.8) | 622 (17.5) |
| FBG, mmol/L | 5.63 ± 1.72 | 5.48 ± 1.62 | 5.73 ± 1.70 | 5.97 ± 1.91 | 6.08 ± 2.05 |
| TC, mmol/L | 4.99 ± 1.20 | 4.52 ± 0.674 | 5.3 ± 1.45 | 5.92 ± 1.45 | 6.60 ± 0.97 |
| HDL-C, mmol/L | 1.56 ± 0.50 | 1.56 ± 0.496 | 1.57 ± 0.508 | 1.56 ± 0.46 | 1.55 ± 0.45 |
| LDL-C, mmol/L | 2.62 ± 0.93 | 2.37 ± 0.838 | 2.79 ± 0.865 | 3.07 ± 0.85 | 3.48 ± 1.00 |
| TG, mmol/L | 1.70 ± 1.70 | 1.38 ± 1.11 | 1.92 ± 1.96 | 2.43 ± 2.50 | 2.66 ± 2.55 |
| Non-HDL-C, mmol/L | 3.43 ± 1.20 | 2.97 ± 0.704 | 3.73 ± 1.45 | 4.36 ± 1.41 | 5.05 ± 0.861 |
| BMI, kg/m2 | 25.08 ± 3.38 | 24.72 ± 3.37 | 25.47 ± 3.31 | 25.80 ± 3.36 | 26.03 ± 3.24 |
| Lipid-lowing drugs, n% | 782 (1.6) | 298 (1.0) | 219 (2.2) | 143 (2.6) | 122 (3.4) |
| Antihypertensive drugs, n% | 5,003 (10.1) | 2,381 (7.8) | 1,180 (11.8) | 837 (15.0) | 605 (17.1) |
| Hypoglycemic drugs, n% | 1,511 (3.0) | 674 (2.2) | 389 (3.9) | 283 (5.1) | 165 (4.7) |
ASCVD, atherosclerotic cardiovascular disease; BP, blood pressure; BMI, body mass index; DM, diabetes mellitus; FBG, fasting blood glucose; HTN, hypertension; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; non-HDL-C, non-high-density lipoprotein cholesterol; TC, total cholesterol; TG, triglyceride.